Medicine and Dentistry
Skin Cancer
40%
Nodular Melanoma
37%
Retrospective Cohort Study
37%
Rheumatoid Arthritis
33%
Psoriatic Nails
33%
Decubitus
33%
Tazarotene
33%
Dermatitis
33%
Ultraviolet Phototherapy
33%
Malassezia Folliculitis
33%
Nail Psoriasis
33%
Systematic Review
33%
Meta-Analysis
33%
Squamous Cell Carcinoma
33%
Adverse Outcome
33%
Nail Disease
33%
Melanoma Cell
33%
Tumor Suppressor Protein
33%
microRNA 21
33%
Vitiligo
33%
Major Surgery
33%
Gram Staining
33%
Etanercept
33%
Phototherapy
22%
Psoriasis
16%
Skin Defect
13%
Tumor Necrosis Factor
13%
Experimental Therapy
11%
Psoriasis Severity Index
11%
Systemic Therapy
11%
Surgical Mortality
10%
Adverse Event
8%
Neoplasm
7%
Reverse Transcription Polymerase Chain Reaction
7%
Keratinocyte
7%
Granuloma
6%
Systemic Disease
6%
Differential Diagnosis
6%
Exanthem
6%
Papule
6%
Microscopy
6%
Neutrophil
6%
Lower Leg
6%
Histiocyte
6%
Folliculitis
5%
Low Level Laser Therapy
5%
Placebo-Controlled Study
5%
Sensitivity and Specificity
5%
Acne Vulgaris
5%
Treatment Response
5%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Mitogen Activated Protein Kinase 3
53%
Vemurafenib
33%
Binding Protein
33%
Squamous Cell Carcinoma
33%
microRNA 21
33%
Microphthalmia Associated Transcription Factor
33%
Lapatinib
33%
Link Protein
33%
Colorectal Tumor
33%
Sorafenib
33%
Tumor Suppressor Protein
33%
Sunitinib
33%
Tazarotene
33%
Nail Disease
33%
Nail Psoriasis
33%
Neoplasm
26%
Psoriasis
16%
Drug Resistance
11%
Mouse
9%
Western Blot
9%
Isobutylmethylxanthine
9%
Growth Factor Receptor
6%
Tumor Regression
6%
Colorectal Cancer
6%
Tumor Resistance
6%
Cause of Death
6%
Colon Cancer
6%
Malignant Neoplasm
6%
Skin Cancer
6%
Adverse Event
5%
Placebo-Controlled Study
5%
Retinoid
5%
Biochemistry, Genetics and Molecular Biology
Tumor Suppressor Protein
33%
MicroRNA
33%
Chromosome Segregation
33%
Microphthalmia-Associated Transcription Factor
33%
Response Element
33%
PDCD4
33%
Binding Protein
33%
Cyclic Adenosine Monophosphate
33%
Melanogenesis
11%
Reverse Transcription Polymerase Chain Reaction
6%
Keratinocyte
6%
IBMX
5%
